Suchergebnisse - "María Ruiz-Ruigómez"

PubPharm (8)

1

Characteristics of clinical trials of influenza and respiratory syncytial virus registered in ClinicalTrials.gov between 2014 and 2021

in: Frontiers in Public Health | 2023

von David Lora | David Lora | David Lora | +13

2

Prognostic factors of OXA-48 carbapenemase-producing Klebsiella pneumoniae infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study

in: International Journal of Infectious Diseases | 2022

von Laura Corbella | Mario Fernández-Ruiz | María Ruiz-Ruigómez | +9

3

Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment

in: Journal of Global Antimicrobial Resistance | 2022

von Pilar Hernández-Jiménez | Francisco López-Medrano | Mario Fernández-Ruiz | +10

4

Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

in: Microorganisms | 2022

von Roberto Vázquez | Roberto Díez-Martínez | Pilar Domingo-Calap | +8

5

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)

in: Journal of Fungi | 2022

von María Ruiz-Ruigómez | Mario Fernández-Ruiz | Ana Pérez-Ayala | +1

6

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.

in: PLoS Pathogens | 2021

von Patricia Almendro-Vázquez | Rocio Laguna-Goya | Maria Ruiz-Ruigomez | +19

7

A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID

in: Biomedicines | 2021

von Alberto Utrero-Rico | María Ruiz-Ruigómez | Rocío Laguna-Goya | +9

8

Real-World Experience with Bezlotoxumab for Prevention of Recurrence of

in: Journal of Clinical Medicine | 2020

von Rosa Escudero-Sánchez | María Ruiz-Ruigómez | Jorge Fernández-Fradejas | +16

1
[1]